Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Medicine Plus is Scopus-indexed (Q2, CiteScore 3.3), WoS ESCI, DOAJ. Published by KeAi Publishing Communications Ltd..
Checked against the index lists dated .
ISSN 2097-289XVerify ISSN ↗2950-3477Verify ISSN ↗
Publisher: KeAi Publishing Communications Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 188 / 466 | 59th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2024–present, best quartile Q2, CiteScore 3.3.
Medicine Plus is Q2 in Medicine (miscellaneous) (rank 188 of 466), by CiteScore 2025.
Medicine Plus is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.3, which places it in quartile Q2 at the 59th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.452, quartile Q3, with an H-index of 6.
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Medicine Plus is published by KeAi Publishing Communications Ltd. Its print ISSN is 2097-289X and its online ISSN is 2950-3477.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Medicine Plus has an h-index of 11 and a 2-year mean of 4.27 citations per paper (OpenAlex). Its Scopus CiteScore is 3.3, quartile Q2. On 2-year citations it ranks #61 of 451 Scopus journals in Medicine (miscellaneous).
Medicine Plus published 33 papers in 2025; its busiest recent year was 2024 with 41. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2024–2026), authors are most often from China (84.2%), United States (5.4%) and Germany (1.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.